Angiodynamics (ANGO) Other Non-Current Liabilities (2012 - 2026)

Angiodynamics (ANGO) has reported Other Non-Current Liabilities for 15 consecutive years, with $16.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Liabilities fell 3.54% year-over-year to $16.3 million; the trailing twelve-month figure through May 2026 stood at $16.3 million (down 3.54% YoY), and the FY2026 full-year result was $16.3 million, down 3.54% from the prior year.
• Other Non-Current Liabilities retreated to $16.3 million in Q2 2026 per ANGO's latest filing, from $16.7 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $17.4 million in Q1 2025 and bottomed at $2.6 million in Q4 2023.
• Historically, Other Non-Current Liabilities has averaged $12.2 million across 5 years, with a median of $14.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities plunged 71.32% in 2023, then surged 355.53% in 2024.
• Over 5 years, Other Non-Current Liabilities stood at $9.1 million in 2022, then slumped by 71.32% to $2.6 million in 2023, then soared by 355.53% to $11.9 million in 2024, then jumped by 43.88% to $17.1 million in 2025, then dropped by 4.39% to $16.3 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $16.3 million, $16.7 million, and $17.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.